[go: up one dir, main page]

UA70349C2 - Use of pyridazine[4,5-?]indole-1-acetamide for preuse of pyridazine[4,5-?]indole-1-acetamide for preparing medicines for treating diseases related to paring medicines for treating diseases related to peripheral benzodiazepin receptor dysfunction peripheral benzodiazepin receptor dysfunction - Google Patents

Use of pyridazine[4,5-?]indole-1-acetamide for preuse of pyridazine[4,5-?]indole-1-acetamide for preparing medicines for treating diseases related to paring medicines for treating diseases related to peripheral benzodiazepin receptor dysfunction peripheral benzodiazepin receptor dysfunction Download PDF

Info

Publication number
UA70349C2
UA70349C2 UA2001074907A UA2001074907A UA70349C2 UA 70349 C2 UA70349 C2 UA 70349C2 UA 2001074907 A UA2001074907 A UA 2001074907A UA 2001074907 A UA2001074907 A UA 2001074907A UA 70349 C2 UA70349 C2 UA 70349C2
Authority
UA
Ukraine
Prior art keywords
indole
disease
acetamide
disorder
pyridazine
Prior art date
Application number
UA2001074907A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Sanofi Synthelabo Sanofi Synth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Sanofi Synth filed Critical Sanofi Synthelabo Sanofi Synth
Publication of UA70349C2 publication Critical patent/UA70349C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UA2001074907A 1999-01-26 2000-01-21 Use of pyridazine[4,5-?]indole-1-acetamide for preuse of pyridazine[4,5-?]indole-1-acetamide for preparing medicines for treating diseases related to paring medicines for treating diseases related to peripheral benzodiazepin receptor dysfunction peripheral benzodiazepin receptor dysfunction UA70349C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900806A FR2788696B1 (fr) 1999-01-26 1999-01-26 Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
PCT/FR2000/000135 WO2000044384A1 (fr) 1999-01-26 2000-01-21 UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES

Publications (1)

Publication Number Publication Date
UA70349C2 true UA70349C2 (en) 2004-10-15

Family

ID=9541212

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001074907A UA70349C2 (en) 1999-01-26 2000-01-21 Use of pyridazine[4,5-?]indole-1-acetamide for preuse of pyridazine[4,5-?]indole-1-acetamide for preparing medicines for treating diseases related to paring medicines for treating diseases related to peripheral benzodiazepin receptor dysfunction peripheral benzodiazepin receptor dysfunction

Country Status (32)

Country Link
US (1) US6395729B1 (pt)
EP (1) EP1148881B1 (pt)
JP (1) JP4688295B2 (pt)
KR (1) KR100694752B1 (pt)
CN (1) CN100577167C (pt)
AR (1) AR022413A1 (pt)
AT (1) ATE335487T1 (pt)
AU (1) AU764445B2 (pt)
BG (1) BG65152B1 (pt)
BR (1) BR0007718A (pt)
CA (1) CA2360754C (pt)
CO (1) CO5160242A1 (pt)
CY (1) CY1106257T1 (pt)
CZ (1) CZ294283B6 (pt)
DE (1) DE60029929T2 (pt)
DK (1) DK1148881T3 (pt)
EE (1) EE04905B1 (pt)
ES (1) ES2269097T3 (pt)
FR (1) FR2788696B1 (pt)
HK (1) HK1040905B (pt)
HU (1) HU228670B1 (pt)
IL (2) IL144181A0 (pt)
NO (1) NO321997B1 (pt)
NZ (1) NZ512981A (pt)
PL (1) PL193420B1 (pt)
PT (1) PT1148881E (pt)
RU (1) RU2243764C2 (pt)
SK (1) SK285707B6 (pt)
TR (1) TR200102134T2 (pt)
TW (1) TW541177B (pt)
UA (1) UA70349C2 (pt)
WO (1) WO2000044384A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201215A2 (en) * 1998-12-02 2002-08-28 Pfizer Prod Inc Methods and compositions for restoring conformational stability of a protein of the p53 family
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
FR2876715B1 (fr) 2004-10-19 2006-12-15 Profiles Du Ct Sa Embout de protection pour ecran de glissiere de securite routiere
GT200600005A (es) * 2005-01-12 2006-08-16 Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
NZ562559A (en) * 2005-05-05 2011-03-31 Sanofi Aventis Us Llc Stable nanoparticle formulations smaller than 1000 nm without the use of any surface modifier or stabilizzer absorbed onto the surface of the particles
EA015715B1 (ru) * 2005-08-29 2011-10-31 САНОФИ-АВЕНТИС Ю. Эс. ЭлЭлСи Твердая дисперсия, фармацевтическая композиция, включающая такую дисперсию, способ ее получения и применение для предотвращения и лечения заболеваний, связанных с бензодиазепиновыми рецепторами периферического типа
CN101253176B (zh) * 2005-08-29 2012-04-18 赛诺菲-安万特美国有限责任公司 哒嗪并[4，5-b]吲哚衍生物的新晶形
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
JP2012500268A (ja) * 2008-08-18 2012-01-05 サノフィ−アベンティス・ユー・エス・エルエルシー ７−クロロ−Ｎ，Ｎ，５−トリメチル−４−オキソ−３−フェニル−３，５−ジヒドロ−４Ｈ−ピリダジノ［４，５−ｂ］インドール−１−アセトアミドの多形体を製造するための方法
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
WO2011073576A2 (fr) 2009-12-18 2011-06-23 L'oreal Procede de coloration de la peau impliquant un compose apte a condenser in situ et un agent colorant de la peau
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121137A1 (de) * 1981-05-27 1982-12-16 Hoechst Ag, 6000 Frankfurt Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6069267A (en) * 1997-07-29 2000-05-30 E. I. Du Pont De Nemours And Company Selective synthesis of organodiphosphite compounds
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
HK1040905A1 (en) 2002-06-28
TW541177B (en) 2003-07-11
HU228670B1 (en) 2013-05-28
IL144181A0 (en) 2002-05-23
NO20013645D0 (no) 2001-07-24
HUP0201280A2 (en) 2002-08-28
CN100577167C (zh) 2010-01-06
PT1148881E (pt) 2006-12-29
SK10502001A3 (sk) 2002-01-07
HUP0201280A3 (en) 2004-12-28
BR0007718A (pt) 2001-11-13
PL349364A1 (en) 2002-07-15
CZ294283B6 (cs) 2004-11-10
KR20010089624A (ko) 2001-10-06
AU3057900A (en) 2000-08-18
ES2269097T3 (es) 2007-04-01
CO5160242A1 (es) 2002-05-30
DK1148881T3 (da) 2006-12-11
EP1148881B1 (fr) 2006-08-09
IL144181A (en) 2007-06-17
CY1106257T1 (el) 2011-06-08
JP4688295B2 (ja) 2011-05-25
FR2788696A1 (fr) 2000-07-28
CN1344161A (zh) 2002-04-10
DE60029929T2 (de) 2007-08-30
BG105728A (en) 2002-02-28
NZ512981A (en) 2002-10-25
SK285707B6 (sk) 2007-06-07
KR100694752B1 (ko) 2007-03-14
ATE335487T1 (de) 2006-09-15
CA2360754A1 (en) 2000-08-03
AU764445B2 (en) 2003-08-21
CA2360754C (en) 2008-07-08
RU2243764C2 (ru) 2005-01-10
FR2788696B1 (fr) 2004-03-05
BG65152B1 (bg) 2007-04-30
JP2002535370A (ja) 2002-10-22
PL193420B1 (pl) 2007-02-28
DE60029929D1 (de) 2006-09-21
EE04905B1 (et) 2007-10-15
WO2000044384A1 (fr) 2000-08-03
CZ20012681A3 (cs) 2001-10-17
NO20013645L (no) 2001-09-26
AR022413A1 (es) 2002-09-04
HK1040905B (zh) 2007-02-23
EE200100388A (et) 2002-12-16
US6395729B1 (en) 2002-05-28
EP1148881A1 (fr) 2001-10-31
NO321997B1 (no) 2006-07-31
TR200102134T2 (tr) 2003-03-21

Similar Documents

Publication Publication Date Title
UA70349C2 (en) Use of pyridazine[4,5-?]indole-1-acetamide for preuse of pyridazine[4,5-?]indole-1-acetamide for preparing medicines for treating diseases related to paring medicines for treating diseases related to peripheral benzodiazepin receptor dysfunction peripheral benzodiazepin receptor dysfunction
KR100370522B1 (ko) 2,4-디술포페닐부틸니트론,그의염및이들의제약스핀트랩으로서의용도
WO2020177292A1 (zh) Rock抑制剂-二氯乙酸复盐及其制备方法和用途
TWI322809B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
US5693645A (en) Use of spiperone or spiperone derivatives as immunosuppressant agents
CN102743382A (zh) 刺激神经形成和抑制神经元变性的方法和组合物
CN113698345B (zh) 作为钾通道调节剂的化合物及其制备和应用
JPH08500326A (ja) 免疫抑制剤としてのスピペロンまたはスピペロン誘導体の使用
WO2020177291A1 (zh) 法舒地尔复合盐及其制备方法和用途
US9932352B2 (en) Compounds for the treatment of ischemia-reperfusion-related diseases
US5574041A (en) Use of spiperone derivatives as immunosuppressant agents
JP4309652B2 (ja) 抗炎症剤
WO2002007727A1 (fr) Utilisation de derives de pyridazino (4, 5) indole-1-acetamide pour la preparation de medicaments destines au traitement des pathologies liees aux dysfonctionnements des recepteurs de type peripherique aux benzodiazepines
MXPA01007550A (en) USE OF PYRIDAZINO[4,5-b
JP7138799B2 (ja) コリンエステラーゼ阻害剤結晶多形及びその使用
JPWO2003087091A1 (ja) キノキサリンジオン誘導体無水物の新規結晶
WO2024051795A1 (zh) 用作泛素-特异性蛋白酶抑制剂的取代嘌呤酮衍生物
CN103374001B (zh) 咪唑并三嗪类mTOR抑制剂